-+ 0.00%
-+ 0.00%
-+ 0.00%
The UK Medicines and Medical Products Authority approved remibutinib for the treatment of chronic spontaneous urticaria in adults.
Share
Listen to the news
The UK Medicines and Medical Products Authority approved remibutinib for the treatment of chronic spontaneous urticaria in adults.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending